Welcome to Alt-Support-Diabetes.org

Alt-Support-Diabetes.org is under new management.

The previous webmaster was discouraged by the lack of interest in the site, and the death of Usenet in general. The active members in the alt.support.diabetes newsgroup weren't even referring to it anymore.

The domain registration for Alt-Support-Diabetes.org was paid years in advance by Mack, who was a frequent poster on the alt.support.diabetes newsgroup and an Alt-Support-Diabetes.org Webmaster. So it doesn't make sense to have a "We're shutdown" message for the next several years. However, it's probable the site will disappear on 12 April 2024.

Some of the information here is very old as the original site was established in 2001 and much of it has never been updated. But it's still a valuable resource. So it's back.

If you would like to contribute content for the site, please contact the ASD Webmaster. Articles attributed to ASD Webmaster as contributor are those for which the true author cannot be determined. If you know who should be credited, please let us know.

Alt-Support-Diabetes (ASD) is an online support group of diabetics, their families and friends. We use this forum to freely share our personal experiences, knowledge, hopes, successes and frustrations concerning diabetes and it's impact on our lives. Currently we are using three major forums: the newsgroup alt.support.diabetes, our IRC chat room, and this website.

Newsgroups are one of the oldest parts of the internet called UseNet. It even pre-dates the World Wide Web. Currently there are over 70,000 individual newsgroups.

We encourage everyone to first read the Newsgroups FAQ. It explains the few do's and don'ts and some basic information about posting to a UseNet forum such as ours.

Disclaimer

The information made available through this web site is not intended to replace the services of a physician. It is provided for informational purposes only and is not a substitute for professional medical advice.

Diabetes News from MIT

01 December 2021

MIT news feed about: Diabetes

Diabetes News from ScienceDaily

30 November 2021

Learn about early diabetes symptoms, diabetic diet information, diabetes care, type 1 diabetes, insulin resistance and type 2 diabetes. Read the latest medical research on diabetes.
  • Experimental compound counters diabetic complications
    An experimental compound reduced complications of type 1 and type 2 diabetes in mice -- not by lowering blood sugar -- but by countering its consequences, a new study finds.
  • Aspirin is linked with increased risk of heart failure in some
    Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition.
  • Twin study finds type 2 diabetes clues in epigenetic changes
    Identical twins share the same DNA, but one twin can suffer from type 2 diabetes while the other twin does not develop the disease. Researchers have now discovered that there are differences in gene activity in twins where only one sibling had developed the disease. The discovery could contribute to the development of new treatment methods.
  • Deleting dysfunctional cells alleviates diabetes
    Eliminating old, dysfunctional cells in human fat also alleviates signs of diabetes, researchers report. The discovery could lead to new treatments for Type 2 diabetes and other metabolic diseases.
  • New link between diet, intestinal stem cells and disease discovered
    Obesity, diabetes and gastrointestinal cancer are frequently linked to an unhealthy diet. However, the molecular mechanisms responsible for this are not fully understood. Researchers have gained some new insights that help to better understand this connection. These findings provide an important basis for the development of non-invasive therapies.